Genesys
Navigation Links
Genesys in Medical News
Hoffa, Cherry to Speak at Community Rally Supporting Genesys Nurses
Rally To Support Local 332 Nurses Negotiating With Genesys Regional Medical Center FLINT, Mich., May 13 /PRNewswire-USNewswire/ -- Teamsters General President Jim Hoffa and Michigan Lt. Gov. John Cherry will lead a rally Wednesday, May 14, 2008, to show community support for more than 1,00...SOUTH SAN FRANCISCO, Calif., March 11 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. (Nasdaq: CEGE ) today announced that Sharon E. Tetlow, senior vice president and chief financial officer of Cell Genesys, will present a company update on Tuesday, March 18 at 8:00 a.m. ET at the Cowen and Comp...
Cell Genesys Reports Fourth Quarter and Year-End 2007 Results
Conference Call Scheduled for 5:00 p.m. ET Today SOUTH SAN FRANCISCO, Calif., Feb. 28 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. (Nasdaq: CEGE ) today reported financial results for the fourth quarter and full year ended December 31, 2007. The company reported a net loss of $33....Cell Genesys, Inc. (Nasdaq: CEGE) today announced follow-up data from a Phase 2 clinical trial of GVAX immunotherapy for pancreatic cancer which was conducted by the Johns Hopkins Sidney Kimmel Cancer Center. The trial enrolled 60 patients with operable pancreatic cancer who received GVAX after su...
Social Entrepreneur's Cup Finalists Announced
...s Today Leaders Forever and the 2008 Social Entrepreneur's Cup winner; and Jeff Tollefson, former venture capitalist and current Executive Director of genesys Works. The Social Entrepreneur's Cup finalists represent the spectrum of social needs including education, health, homelessness, and sustainable ...Best Practices in Asia Pacific Healthcare and ICT Sectors Recognised
...ic Market Leadership F5 Networks Award in the Application Delivery Controller Market 2008 Asia Pacific Market Leadership genesys Telecommunications Award CTI Systems Market Laboratories 2008 Asia Pacific Market Leadership Aspect Software ...Ceregene Completes Enrollment of Phase 2 Clinical Trial for Parkinson's Disease
...former subsidiary of Cell Genesys, Inc. (Nasdaq: CEGE ). The company's investors include Alta Partners, MPM Capital, Investor Growth Capital and Cell genesys as well as Hamilton BioVentures and California Technology Partners. ...HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes
... 224436920.1 BioCryst Pharmaceutical Inc BCRX 216859123.5 Xoma Ltd (Bermuda) XOMA 735715935.4 Cell genesys Inc CEGE 542413535.1 Progenics Pharmaceuticals Inc PGNX 78957476.65 Gtx Inc GTXI...New lung cancer vaccine on the anvil
...tudy is really good proof of principle that immune therapies can be translated from interesting lab findings into the treatment of patients. Cell genesys Inc., in Foster City, Calif., is developing the vaccine as a cancer treatment. The company is sponsoring phase II safety/efficacy clinical trials. ...Genesys in Medical Technology
SOUTH SAN FRANCISCO, Calif., Feb. 15 /PRNewswire-FirstCall/ -- Cell
Genesys, Inc. (Nasdaq: CEGE ) today reports the results of an analysis
examining the potential association between immune responses to GVAX
immunotherapy for prostate cancer and increased patient survival in a Phase
2 trial i...
SOUTH SAN FRANCISCO, Calif., April 03, 2007 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. today announced final, updated results from its second multi-center Phase 2 trial of GVAX immunotherapy for prostate cancer which evaluated escalating doses of the immunotherapy in 80 patients with metastatic ...
SOUTH SAN FRANCISCO, Calif., April 17, 2007 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. today reported immune response data from two previously conducted Phase 2 clinical trials of GVAX immunotherapy for prostate cancer. Evaluation of antibody responses in patients with advanced prostate cancer f...
SOUTH SAN FRANCISCO, Calif., June 04, 2007 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. today announced follow-up data from a Phase 2 clinical trial of GVAX immunotherapy for pancreatic cancer which was conducted by the Johns Hopkins Sidney Kimmel Cancer Center. The trial enrolled 60 patients with...
...that study is performed according to the SPA. Cell genesys completed the modifications requested by FDA durin... Conference Call and Webcast Members of the Cell genesys management team will host a conference call today,...ence call live on the investor section of the Cell genesys website, http://www.cellgenesys.com . Alternative...
... indicate that antiplatelet therapy is an important factor relating to the occurrence of stent thrombosis in DES patients," said Dr. Dobies, Director, genesys Heart Institute, Grand Blanc, Michigan. "Other significant predictors change from one to two years, suggesting differences in pathophysiology that may...
SOUTH SAN FRANCISCO, Calif., April 03, 2007 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. today announced final, updated results from its second multi-center Phase 2 trial of GVAX immunotherapy for prostate cancer which evaluated escalating doses of the immunotherapy in 80 patients with metastatic ...
SOUTH SAN FRANCISCO, Calif., April 17, 2007 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. today reported immune response data from two previously conducted Phase 2 clinical trials of GVAX immunotherapy for prostate cancer. Evaluation of antibody responses in patients with advanced prostate cancer f...
SOUTH SAN FRANCISCO, Calif., June 04, 2007 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. today announced follow-up data from a Phase 2 clinical trial of GVAX immunotherapy for pancreatic cancer which was conducted by the Johns Hopkins Sidney Kimmel Cancer Center. The trial enrolled 60 patients with...
...that study is performed according to the SPA. Cell genesys completed the modifications requested by FDA durin... Conference Call and Webcast Members of the Cell genesys management team will host a conference call today,...ence call live on the investor section of the Cell genesys website, http://www.cellgenesys.com . Alternative...
Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease
...former subsidiary of Cell Genesys, Inc. (Nasdaq: CEGE ). The company's investors include Alta Partners, MPM Capital, Investor Growth Capital and Cell genesys as well as Hamilton BioVentures and California Technology Partners. ...... indicate that antiplatelet therapy is an important factor relating to the occurrence of stent thrombosis in DES patients," said Dr. Dobies, Director, genesys Heart Institute, Grand Blanc, Michigan. "Other significant predictors change from one to two years, suggesting differences in pathophysiology that may...
Genesys in Biological Technology
Cell Genesys to Present at the BIO CEO and Investor Conference
SOUTH SAN FRANCISCO, Calif., Feb. 4 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. (Nasdaq: CEGE ) today announced that Stephen A. Sherwin, M.D., chairman and chief executive officer of Cell Genesys, will present a company update at the BIO CEO and Investor Conference in New York, New York, on ...Cell Genesys Announces Sale of Lentiviral Gene Delivery Technology for $12 Million
SOUTH SAN FRANCISCO, Calif., and GREENWICH, Conn., Dec. 20 /PRNewswire- FirstCall/ -- Cell Genesys, Inc. (Nasdaq: CEGE ) and GBP IP, LLC, an affiliate of GBP Capital, the majority shareholder in privately held Lentigen Corporation, today announced that the two companies have entered into an a...Cell Genesys to Webcast Third Quarter 2007 Conference Call
SOUTH SAN FRANCISCO, Calif., Oct. 25 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. (Nasdaq: CEGE ), today announced that Stephen A. Sherwin, M.D., chairman and chief executive officer, and Sharon E. Tetlow, senior vice president and chief financial officer of Cell Genesys, will host a conferen...Cell Genesys to Present at the BIO Investor Forum
SOUTH SAN FRANCISCO, Calif., Oct. 3 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. (Nasdaq: CEGE ), today announced that Robert Dow, MBChB, chief medical officer of Cell Genesys, will present a company update on Wednesday, October 10, at 10:15 a.m. PT at the BIO Investor Forum being held in San...Cell Genesys to Present at the Bear Stearns 20th Annual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Sept. 4 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. (Nasdaq: CEGE ), today announced that Sharon E. Tetlow, senior vice president and chief financial officer of Cell Genesys, will present a company update at the Bear Stearns 20th Annual Healthcare Conference in N...New Report Just Published: World Prostate Cancer Therapeutics Market Report
...Medimmune, LLC, Bristol-Myers Squibb Company, Cell genesys Inc., Dendreon Corporation, EUSA Pharma, (USA) Inc... Bavituximab in Prostate Cancer II-54 Cell genesys Reveals Data of GVAX Immunotherapy for Treatment ...or New Prostate Cancer Compound II-71 Cell genesys Forms Global Alliance with Takeda on GVAX Immu...Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
...UTICS INC. (NASDAQ: ALTH ) ARQULE INC. (NASDAQ: ARQL ) ARRAY BIOPHARMA INC. (NASDAQ: ARRY ) BIOCRYST PHARMACEUTICALS INC. (NASDAQ: BCRX ) CELL genesys INC. (NASDAQ: CEGE ) DENDREON CORP (NASDAQ: DNDN ) DYNAVAX TECHNOLOGIES CORP (NASDAQ: DVAX ) GPC BIOTECH AG-ADR (NASDAQ: GPCB ) IMMUNOGEN INC....Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
... served as a member of the board of directors of Monogram Biosciences (MGRM), Inc., a publicly-traded biotechnology company; and the advisory board of genesys Capital, a venture capital firm. He is the author or inventor of over 40 publications and patents. Mendlein earned his Ph.D. in physiology and biophys...Ceregene Appoints Joao Siffert, M.D. to the Position of Chief Medical Officer
... respectively. Ceregene was launched in January 2001, and the company's investors include Alta Partners, MPM Capital, Investor Growth Capital and Cell genesys (Nasdaq: CEGE ), as well as Hamilton BioVentures and California Technology Partners. ...Other TagsThyroidThyroidThyroidTibiaTongueTobaccoTobaccoTracheaTraitTraitOther Contentssepticsepticsepticsepticseptumserologyserologyironironironironironironironironcalciumcalciumcalciumcalciumcalciumcalciumcalciumcalciumcalciumphosphorusphosphorusphosphorusphosphorusphosphorusphosphoruseducationeducationeducationeducationeducationeducationeducationeducation
ThalassemiaThallusThermoregulationThoraxThymineThylakoidThylakoidsThyroidTibiaTongueTobaccoTracheaTraitTracheae
(Date:11/27/2009)..., DALLAS,Nov.27/PRNewswire-USNewswire/--Conside...y25yearsago,solidorgantransplantationisnowalife-sa...andwomenwhogatheredattheWinspearOperaHouseinDallas...ndtheworldtocelebratethe25thanniversaryofBaylorReg...olidorgantransplantintheUnitedStates. ,, Itwas2...
(Date:11/27/2009)... , ROCHESTER, N.Y., Nov. 27 /PRNewswire-USNe... health care provider and fortunately every year, ...prevention. But do all vaccines boost immunity for...ditional ,booster shots, needed to keep immunity s..., the Journal of the American Academy of Pediatric...
(Date:11/27/2009)... , KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewswir...aq: SHMR ) ( "Shamir" ), a leading provider of in... lens market, announced today that its board of di... aggregate amount of US$ 10 million (approximately...representative rate of exchange), or approximately...
(Date:11/27/2009)...king and cycling plus low-emission vehicles may re... , FRIDAY, Nov. 27 (HealthDay News) -- Encour... using cars would offer much greater public health...cles, U.K. researchers have found. , The study ...lternative urban land transport scenarios for Lond...
(Date:11/27/2009)..., SEATTLE,Nov.27/PRNewswire/-- Allrecipes.com ...vingtrafficnumbers,withmorethan2.8millionvisitorst...atwasservedonthebiggestfoodholidayoftheyear.Theave...perserving,a5percentincreasefromlastyear,sfeast.Ac...heshowasthemostpopularThanksgivingrecipe,acontrast...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3[0] Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary[0] Why Some Vaccines May Require A Booster[0] Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend[0] More Foot Power, Less Car Pollution Best for Health[0] It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories
(Date:11/25/2009)... stomach, may be used to boost resistance to, or s...School of Medicine researchers report in a study p...oscience . , Parkinson,s disease is caused by a ... midbrain known as the substantia nigra, which is ...uction of dopamine in late-stage Parkinson,s cause...
(Date:11/25/2009)... heart pumps some 250 million liters of blood thro...fibers of the heart have to be extremely durable. ...r, vice chair of the Department of Medicine III at...r. H. A. Katus), has discovered a protein that is ...ular unit, the sarcomere. In cooperation with othe...
(Date:11/24/2009)...s to understanding how sounds associated with Navy... or if they hear it at all. , The same type of ...es to detect flaws in the space shuttle,s behemoth...peek inside the giant head of a whale. The scans a...f a whale,s hearing anatomy using a breakthrough m...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2New genetic cause of cardiac failure discovered 2Rocket science leads to new whale discovery 22009 National Ergonomics Conference Coming To Las Vegas In November 3B Features Strategies For Dealing With A Slow Economy 26amp 3B Aging Workforce I 58536 12009 National Ergonomics Conference Coming To Las Vegas In November 3B Features Strategies For Dealing With A Slow Economy 26amp 3B Aging Workforce I 58536 22009 National Ergonomics Conference Coming To Las Vegas In November 3B Features Strategies For Dealing With A Slow Economy 26amp 3B Aging Workforce I 58536 32009 National Ergonomics Conference Coming To Las Vegas In November 3B Features Strategies For Dealing With A Slow Economy 26amp 3B Aging Workforce I 58536 4Noteworthy Medical Systems Selected as a Preferred EHR Vendor for Arizonas PACeHR Purchasing 26amp 3B Assistance Collaborative 58531 1Noteworthy Medical Systems Selected as a Preferred EHR Vendor for Arizonas PACeHR Purchasing 26amp 3B Assistance Collaborative 58531 2Noteworthy Medical Systems Selected as a Preferred EHR Vendor for Arizonas PACeHR Purchasing 26amp 3B Assistance Collaborative 58531 3Nobelprize org Expands Channels and News Services for the 2009 Nobel Prize Announcements 14296 1Nobelprize org Expands Channels and News Services for the 2009 Nobel Prize Announcements 14296 2Nobelprize org Expands Channels and News Services for the 2009 Nobel Prize Announcements 14296 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |